Search research articles
Contact Us
Filters
Showing results (121-130 of 182) with videos related to
Page
of 19
Sort By:
Postgraduate Medical Journal
|
June 1, 1996
Breathlessness in an Afro-Caribbean woman
H R Roberts, D M Hansell, R Wilson, et al.
Annals of Internal Medicine
|
December 1, 1974
Thrombogenic materials in prothrombin complex concentrates
P M Blatt, R L Lundblad, H S Kingdon, et al.
American Journal of Hematology
|
January 1, 1980
Fibrinogen Chapel Hill: hypodysfibrinogenemia with a tertiary polymerization defect
R P McDonagh, N A Carrell, H R Roberts, et al.
Biochemical and Biophysical Research Communications
|
October 15, 1984
Inactivation of human blood coagulation factor X by chemical modification of gamma-carboxyglutamic acid residues
G B Sherrill, D L Straight, R G Hiskey, et al.
The Journal of Clinical Investigation
|
December 1, 1981
Characterization of the defect in activation of factor IX Chapel Hill by human factor XIa
K M Braunstein, C M Noyes, M J Griffith, et al.
Thrombosis Research
|
December 1, 1975
Prothrombin profragment-1 optical rotatory dispersion and circular dichroism
D A Gabriel, D J Schaefer, H R Roberts, et al.
Blood
|
January 1, 1987
Factor IXAlabama: a point mutation in a clotting protein results in hemophilia B
L M Davis, R A McGraw, J L Ware, et al.
Clinics in Haematology
|
June 1, 1985
Structure and function of factor IX: defects in haemophilia B
R A McGraw, L M Davis, R L Lundblad, et al.
Biochemistry
|
December 31, 1985
Comparison of lipid binding and kinetic properties of normal, variant, and gamma-carboxyglutamic acid modified human factor IX and factor IXa
M E Jones, M J Griffith, D M Monroe, et al.
Thrombosis and Haemostasis
|
March 11, 1998
Cloning, expression, and characterization of mouse tissue factor pathway inhibitor (TFPI)
J Y Chang, D M Monroe, J A Oliver, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 182) with videos related to
Sort By:
Page
of 19
Postgraduate Medical Journal
|
June 1, 1996
Breathlessness in an Afro-Caribbean woman
H R Roberts, D M Hansell, R Wilson, et al.
Annals of Internal Medicine
|
December 1, 1974
Thrombogenic materials in prothrombin complex concentrates
P M Blatt, R L Lundblad, H S Kingdon, et al.
American Journal of Hematology
|
January 1, 1980
Fibrinogen Chapel Hill: hypodysfibrinogenemia with a tertiary polymerization defect
R P McDonagh, N A Carrell, H R Roberts, et al.
Biochemical and Biophysical Research Communications
|
October 15, 1984
Inactivation of human blood coagulation factor X by chemical modification of gamma-carboxyglutamic acid residues
G B Sherrill, D L Straight, R G Hiskey, et al.
The Journal of Clinical Investigation
|
December 1, 1981
Characterization of the defect in activation of factor IX Chapel Hill by human factor XIa
K M Braunstein, C M Noyes, M J Griffith, et al.
Thrombosis Research
|
December 1, 1975
Prothrombin profragment-1 optical rotatory dispersion and circular dichroism
D A Gabriel, D J Schaefer, H R Roberts, et al.
Blood
|
January 1, 1987
Factor IXAlabama: a point mutation in a clotting protein results in hemophilia B
L M Davis, R A McGraw, J L Ware, et al.
Clinics in Haematology
|
June 1, 1985
Structure and function of factor IX: defects in haemophilia B
R A McGraw, L M Davis, R L Lundblad, et al.
Biochemistry
|
December 31, 1985
Comparison of lipid binding and kinetic properties of normal, variant, and gamma-carboxyglutamic acid modified human factor IX and factor IXa
M E Jones, M J Griffith, D M Monroe, et al.
Thrombosis and Haemostasis
|
March 11, 1998
Cloning, expression, and characterization of mouse tissue factor pathway inhibitor (TFPI)
J Y Chang, D M Monroe, J A Oliver, et al.
Page
of 19